ZNF519P3

Across TCGA pan-cancer cohorts, ZNF519P3 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated ZNF519P3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ZNF519P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF519P3 expression acts as an unfavorable survival marker.

STAD, UCEC, and READ are the cancer types where ZNF519P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.177	0.590	<.001	144	view →
UCEC	OS	Tertile	All	0.623	0.873	.018	54	view →
READ	DFS	Tertile	All	0.111	0.799	.001	33	view →
LUSC	OS	Tertile	All	0.503	0.819	<.001	33	view →
LGG	DFS	Tertile	All	0.312	0.759	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ZNF519P3–STAD (OS)

Open the STAD breakdown →